Anna Willox, PhD
Head of European Business Development
As part of Nexus BioQuest’s ongoing commitment to staying at the forefront of immunology and drug discovery, I had the opportunity to attend the SLAS (Society for Laboratory Automation and Screening) meeting in London this December. This event served as an invaluable platform for networking with industry leaders, learning about the latest advancements in laboratory automation, and exploring new technologies that could enhance our offerings at Nexus BioQuest.
Attending SLAS allowed me to connect with potential partners, discover cutting-edge developments in screening technologies, and exchange insights on best practices in drug discovery. I look forward to leveraging the knowledge and relationships gained at the event to help Nexus BioQuest continue to provide top-tier services for our clients, particularly in areas like immune profiling, cell-based assays, and immunotherapy development.
It was a fantastic experience to engage with experts and peers in the field, and I’m excited to see how the connections and insights from SLAS will help Nexus BioQuest expand its capabilities and strengthen its position in the industry. It was a true pleasure meeting so many inspiring individuals, including Sonia Houghton, Del Trezise, Jeroen Verheyen, Scott Mitchell, Dahir Ahmed, Thomas Richardson, Rob Howes, and reconnecting with familiar faces like Tom Crabbe after many years!
A huge thank you to the organizers, SLAS (Vicki Loise) and ELRIG (Sanj Kumar), as well as the sponsors, for creating such a wonderful opportunity to network and hear exciting presentations on innovations in the bioscience and drug discovery sectors, including new modalities.
I’m already looking forward to next year’s events!
How did you celebrate International Day of Immunology? At Nexus BioQuest we celebrated our favorite immune cell. It has been fun to hear from our collaborators what their favorite immune cell is and why?
Dr Rhiannon Jenkinson (CSO) and Jody Sawyer (VP of Business Development) showcased our services spanning preclinical screening, efficacy, translational models, predictive immunotoxicology and clinical Biomarkers, within the IO, Autoimmunity and Inflammatory space. Connecting with our current clients and meeting new ones. We will be back in 2024, continuing to support companies within the west coast Biotech hubs. Watch our Events page to see when we are visiting or Contact Us in the meantime to see how we can help.
Dr Rhiannon Jenkinson (CSO) and Jody Sawyer (VP of Business Development) had a fantastic time at the IO conference in Boston, meeting with current clients and new companies. After spending time at the conference, visiting the Boston Biotech hub and dining with clients the Nexus BioQuest team were extremely grateful for the fruitful discussions and excited about future collaborations. The Nexus Team will be back in Boston in early 2024 to visit clients and later in the year for the Special AACR conference, see more on our Events page. If you are interested in meeting the team in March 2024 Contact Us